New aspects of human trichinellosis: The impact of new Trichinella species

Postgraduate Medical Journal

Volumn 78, Issue 915, 2002, Pages 15-22

  Bruschi, Fabrizio ^a   Murrell, K D ^b  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; ANALGESIC AGENT; ANTIPARASITIC AGENT; ANTIPYRETIC ANALGESIC AGENT; CORTICOSTEROID; FLUCONAZOLE; MEBENDAZOLE; PREDNISOLONE; TIABENDAZOLE;

CLINICAL FEATURE; DRUG EFFICACY; GEOGRAPHIC DISTRIBUTION; HUMAN; INTERNATIONAL COOPERATION; MUSCLE BIOPSY; MYOSITIS; REVIEW; SIDE EFFECT; SPECIES DIFFERENTIATION; SPECIES IDENTIFICATION; TRICHINELLA; TRICHINELLA MURRELLI; TRICHINELLA PAPUAE; TRICHINELLA PSEUDOSPIRALIS; TRICHINELLA SPIRALIS; TRICHINOSIS;

ANIMALS; ANTHELMINTICS; BIOPSY; EOSINOPHILIA; HUMANS; LIFE CYCLE STAGES; MEAT; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; SWINE; TRICHINELLA; TRICHINOSIS; ZOONOSES;

EID: 0036145085     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pmj.78.915.15     Document Type: Review

References (101)

1. Trichinellosis: The zoonosis that won't go quietly
2. The systematics of the genus trichinella with a key to the species
3. Factors affecting the flow among domestic, synanthropic and sylvatic cycles of trichinella
4. Detection of parasites in food
5. Trichinosis in the Canadian arctic: Report of five outbreaks and a new clinical syndrome
6. Arctic trichinosis presenting as prolonged diarrhea
7. Generation and expression of Trichinella spiralis immunity
8. Delayed expulsion of the nematode Trichinella spiralis in mice lacking the mucosal mast cell-specific granule chymase, mouse mast cell protease-1
9. Increase of mucosal mast cells in the jejunum of patients infected with Trichinella spiralis
10. Pathophysiology of the gastrointestinal phase
11. Prospective rheumatological study of muscle and joint symptons during Trichinella nelsoni infection
12. Trichinella spiralis
13. Neurotoxicity of human eosinophils
14. Trichinosis of the central nervous system
15. Immunopathological mechanisms underlying the time course of Trichinella spiralis cardiomyopathy in rats
16. Differentiation of bone marrow cells into effector cells
17. The eosinophil stimulation promoter test in murine and human Trichinella spiralis infection
18. Cytokine regulation of host defense against parasitic gastrointestinal nematodes. Lessons from studies with rodent models
19. Apoptosis and in vivo distribution and clearance of eosinophils in normal and Trichinella spiralis-infected rats
20. IgE antibody and resistance to infection. I. Selective suppression of the IgE antibody response in rats diminishes the resistance and the eosinophil response to trichinella infection
21. Protective immunity and eosinophilia in IgE-deficient SJA/9 mice infected with Nippostrongylus brasiliensis and Trichinella spiralis
22. Immunology of Trichinella spiralis infection
23. Antibody-dependent "in vitro" cytotoxicity of newborn Trichinella spiralis larvae. Nature of the cells involved
24. Host defense mechanisms against nematode parasites: Destruction of newborn Trichinella spiralis larvae by human antibodies and granulocytes
25. Immune killing of newborn trichinella larvae by human leukocytes
26. Damage to Trichinella spiralis newborn larvae by eosinophil major basic protein
27. Killing of newborn larvae of Trichinella spiralis by eosinophil peroxidase in vitro
28. Mechanisms of killing of newborn larvae of Trichinella spiralis by neutrophils and eosinophils. Killing by generators of hydrogen peroxide in vitro
29. Depletion of eosinophils by IL-5 monoclonal antibody treatment of mice infected with Trichinella spiralis does not alter parasite burden or immunologic resistance to reinfection
30. IL-5 contributes to worm expulsion and muscle hypercontractility in a primary T spiralis infection
31. Marked eosinophilia in interleukin-5 transgenic mice fails to prevent Trichinella spiralis infection
32. Interleukin-5 deficient mice exhibit impaired host defence against challenge Trichinella spiralis infections
33. Biological and immunological characteristics of Trichinella pseudospiralis
34. A role for elevated plasma corticosterone in modulation of host response during infection with Trichinella pseudospiralis
35. First outbreak of human trichinellosis caused by Trichinella pseudospiralis
36. Clinical aspects in man
37. Trichinose humaine et immuno-depression. Un cas chez un greffé renal
38. T spiralis: Differences between "early" and "late" rapid expulsion evident from inhibition studies using cortisone and irradiation
39. Clinical aspects of infection with Trichinella spp.
40. Clinic of trichinellosis
41. Evaluation of some immunological parameters in trichinellosis patients with periorbital edema
42. An outbreak of trichinosis in Pennsylvania
43. Trichinosis with ventilatory failure and persistent myocarditis
44. Clinical manifestations, a. Symptomatology
45. Trichinosis
46. Trichinella spiralis infection of the central nervous system
47. Myocarditis caused by Trichinella spiralis
48. Parasitologic examination of muscles several years after trichinosis
49. Biological characterizations of trichinella isotates from various host species and geographical regions
50. Chronic trichinosis. Clinical, bioptic, serological and electromyographic observations
51. Controversial aspects in human trichinellosis
52. Sequelae after infection with Trichinella spiralis: A prospective cohort study
53. Trichinosis: A prospective controlled study of patients 10 years after acute infection
54. Trichinellosis in the United States, 1991-1996: Declining but not gone
55. Pathophysiological aspects of trichinella infection in man
56. Electromyographic studies in persons with trichinellosis hystory
57. Anatomic pathology
58. Clinical trichinellosis
59. Trichinellosis
60. Alterations in the longevity and fecundity of adult Trichinella pseudospiralis related to the method of isolation of infective larvae
61. Random amplified polymorphic DNA fingerprints of the eigth taxa of trichinella and their comparison with allozyme analysis
62. Identification of Trichinella pseudospiralis from a human case using random amplified polymorphic DNA
63. Anatomical pathology
64. Trichinelloidea: Trichuris, trichinella and capillaria-diocto-phymatoidea: Dioctophyme
65. Multifocal central nervous system lesions on three patients with trichinosis
66. Difficulties in diagnosing trichinella encephalitis
67. Creatine kinase isoenzymes in human trichinellosis
68. The diagnostic value of enzymatic and immunological test in human trichinellosis
69. Studies of immunoglobulins, bentonite flocculation and IgE, IgG and IgM antibodies in serum from patients with trichinosis
70. Specific and total IgE in human trichinellosis infection. Use of an amplified ELISA system
71. Immunodiagnosis in man
72. Dynamics and persistence of antibodies in trichinellosis
73. Etude des immunoglobulines specifiques (totales, IgG, IgM, IgA, IgE) en immunofluorescence indirecte et en ELISA chez quarante malades trichinés suivis pendant neuf mois
74. Immunofluorescence in the serological diagnosis of Trichinella spiralis infection
75. Antibody response to Trichinella spiralis
76. Detection of human antibodies to Trichinella spiralis by enzyme-linked immunosorbent assay (ELISA)
77. Study of acute trichinosis in Ghurkas: Specificity and sensitivity of enzyme-linked immunosorbent assay for IgM and IgE antibodies to trichinella larvae antigens in diagnosis
78. Immunodiagnosis of human trichinellosis and identification of specific antigen for Trichinella spiralis
79. Investigation of immunofluorescence cross-reaction against Trichinella spiralis by Western blot (immunoblot) analysis
80. Workshop on characterization and standardization of trichinella antigens
81. Workshop on a detailed characterization of Trichinella spiralis antigens. A platform for future studies on antigens and antibodies to this parasite
82. Molecular cloning and expression of an immunodominant 53-Kda excretory-secretory antigen from Trichinella spiralis muscle tarvae
83. Use of a synthetic antigen for the serological diagnosis of human trichinellosis
84. Detection of specific immunoglobulins (IgG, IgM, IgA, IgE) and total IgE levels in human trichinosis by means of the enzyme-linked immunosorbent assay (ELISA)
85. Parasite-specific antibody response in Trichinella sp 3 human infection: A one year follow up
86. Persistence of immune response in patients chronically affected by trichinellosis
87. The sequential appearence of IgG subclasses and IgE during the course of Trichinella spiralis infection
88. Comparative efficacy of antigen and antibody detection tests for human trichinellosis
89. Antigenic characteristics of two strains of Trichinella spiralis isolated during the horsemeat-related outbreaks of 1985 in France
90. Comparison of human trichinellosis caused by Trichinella spiralis and Trichinella britovi
91. Trichinella pseudospiralis outbreak in France
92. Proliferation of human peripheral blood mononuclear cells induced by Trichinella spiralis and Trichinella britovi antigens
93. Trichinellosis: Human disease, diagnosis and treatment
94. Meatborne helminth infections: Trichinellosis
95. Blinded, placebo-controlled trial of antiparasitic drugs for trichinosis myositis
96. Failure of mebendazole in the treatment of humans with Trichinella spiralis infection at the stage of encapsulated larvae
97. Drugs for parasitic infections
98. Trichinosis
99. Randomized trial of albendazole versus thiabendazole plus flubendazole during an outbreak of human trichinellosis
100. Eosinofili ed eosinofilia in immunoparassitologia